Marton Laurence 4
4 · RenovoRx, Inc. · Filed May 6, 2025
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Marton Laurence
Director
Transactions
- Exercise/Conversion
Common Stock
2025-05-02$0.15/sh+20,480$3,072→ 66,164 total - Exercise/Conversion
Stock Option (right to buy)
2025-05-02−20,480→ 0 totalExercise: $0.15Exp: 2025-10-14→ Common Stock (20,480 underlying)
Footnotes (2)
- [F1]Represents the reporting person's cash exercise of an outstanding stock option into shares of common stock, with no sale of such shares of common stock.
- [F2]Shares subject to the option are fully vested and immediately exercisable.